Optimal design and patient selection for interventional trials using radiogenomic biomarkers: A REQUITE and Radiogenomics consortium statement

The optimal design and patient selection for interventional trials in radiogenomics seem trivial at first sight. However, radiogenomics do not give binary information like in e.g. targetable mutation biomarkers. Here, the risk to develop severe side effects is continuous, with increasing incidences...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Radiother Oncol
Autors principals: De Ruysscher, Dirk, Defraene, Gilles, Ramaekers, Bram L.T., Lambin, Philippe, Briers, Erik, Stobart, Hilary, Ward, Tim, Bentzen, Søren M, Van Staa, Tjeerd, Azria, David, Rosenstein, Barry, Kerns, Sarah, West, Catharine
Format: Artigo
Idioma:Inglês
Publicat: 2016
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5557371/
https://ncbi.nlm.nih.gov/pubmed/27979370
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.radonc.2016.11.003
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars